Can you provide the average price target for XPENG INC - ADR stock?
34 analysts have analysed XPEV and the average price target is 25.94 USD. This implies a price increase of 29.9% is expected in the next year compared to the current price of 19.97.
NYSE:XPEV • US98422D1054
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XPENG INC - ADR (XPEV).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-06 | Freedom Capital Markets | Upgrade | Hold -> Buy |
| 2025-08-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-19 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-15 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-05-22 | Macquarie | Upgrade | Neutral -> Outperform |
| 2025-03-20 | Barclays | Maintains | Underweight -> Underweight |
| 2025-03-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-19 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-10 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-02-24 | UBS | Upgrade | Sell -> Neutral |
| 2025-02-07 | Macquarie | Downgrade | Outperform -> Neutral |
| 2024-12-05 | UBS | Downgrade | Neutral -> Sell |
| 2024-11-22 | China Renaissance | Upgrade | Hold -> Buy |
| 2024-11-20 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2024-11-20 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-09-05 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-08-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-21 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-07-16 | B of A Securities | Maintains | Buy -> Buy |
| 2024-06-25 | Citigroup | Upgrade | Sell -> Neutral |
| 2024-04-15 | Macquarie | Reiterate | Neutral |
| 2024-03-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-02-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-09-22 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 26.855B 27.95% | 30.676B 14.23% | 40.866B 33.22% | 79.02B 93.36% | 104.413B 32.13% | 127.705B 22.31% | 141.409B 10.73% | 158.585B 12.15% | 176.673B 11.41% | 194.223B 9.93% | 215.576B 10.99% | 233.106B 8.13% | |
| EBITDA YoY % growth | -7.568B -30.87% | -7.906B -4.46% | -3.702B 53.18% | -963.252M 73.98% | 3.07B 418.71% | 5.466B 78.05% | 11.108B 103.22% | 12.519B 12.70% | 14.096B 12.60% | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.55B -33.96% | -9.782B -14.42% | -5.811B 40.60% | -3.028B 47.89% | -92.236M 96.95% | 2.76B 3,092.31% | 7.993B 189.60% | 11.76B 47.13% | 14.313B 21.71% | 16.652B 16.34% | 19.26B 15.66% | 21.246B 10.31% | |
| Operating Margin | -31.84% | -31.89% | -14.22% | -3.83% | -0.09% | 2.16% | 5.65% | 7.42% | 8.10% | 8.57% | 8.93% | 9.11% | |
| EPS YoY % growth | -10.49 -92.83% | -11.96 -14.01% | -6.11 48.91% | -1.61 73.63% | 0.70 143.35% | 3.46 394.97% | 4.06 17.29% | 5.18 27.85% | 5.92 14.26% | N/A | N/A | N/A |
All data in CNY
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 76.29% | -0.34 50.93% | 0.20 140.32% | 0.43 208.46% | 0.44 231.07% | 0.40 216.70% | 0.48 138.78% | 0.31 -29.47% | 0.56 28.02% |
| Revenue Q2Q % growth | 22.574B 40.17% | 17.725B 12.11% | 27.269B 49.22% | 28.71B 40.87% | 31.443B 39.29% | 27.981B 57.86% | 30.842B 13.10% | 33.991B 18.39% | 38.352B 21.97% |
| EBITDA Q2Q % growth | -451.793M -229.54% | -216.99M 88.40% | -521.451M -193.52% | 76.493M 114.50% | 251.06M 155.57% | 348.36M 260.54% | 537.06M 202.99% | 114.26M 49.37% | 610.92M 143.34% |
| EBIT Q2Q % growth | -570.56M 67.59% | -723.505M 21.63% | 170.26M 128.44% | 320.88M 147.38% | 725.68M 227.19% | 348.36M 148.15% | 537.06M 215.44% | 114.26M -64.39% | 610.92M -15.81% |
All data in CNY
34 analysts have analysed XPEV and the average price target is 25.94 USD. This implies a price increase of 29.9% is expected in the next year compared to the current price of 19.97.
XPENG INC - ADR (XPEV) will report earnings on 2026-03-20, before the market open.
The consensus EPS estimate for the next earnings of XPENG INC - ADR (XPEV) is -0.33 USD and the consensus revenue estimate is 22.57B USD.
The number of analysts covering XPENG INC - ADR (XPEV) is 34.